Eureka Forbes Ltd
Eureka Forbes Limited (EFL) is a part of the private equity firm advent which was bought from Shapoorjipallonji group company forbes LTD . Company is engaged in the health & hygiene segment with product profiles comprising water purifiers, vacuum cleaners, air purifiers, and home security systems.[1]
- Market Cap ₹ 10,348 Cr.
- Current Price ₹ 535
- High / Low ₹ 656 / 452
- Stock P/E 61.6
- Book Value ₹ 228
- Dividend Yield 0.00 %
- ROCE 5.07 %
- ROE 3.71 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.45% over last 3 years.
- Promoters have pledged or encumbered 53.7% of their holding.
- Promoter holding has decreased over last 3 years: -10.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 8 | 382 | 2,085 | 2,189 | 2,437 | 2,491 | |
| 9 | 363 | 1,939 | 1,991 | 2,171 | 2,221 | |
| Operating Profit | -1 | 18 | 145 | 199 | 266 | 271 |
| OPM % | -17% | 5% | 7% | 9% | 11% | 11% |
| 0 | 2 | -30 | -6 | 19 | 24 | |
| Interest | 0 | 4 | 20 | 10 | 6 | 5 |
| Depreciation | 0 | 9 | 56 | 54 | 58 | 60 |
| Profit before tax | -2 | 7 | 39 | 128 | 221 | 230 |
| Tax % | 1% | 63% | 31% | 26% | 26% | |
| -2 | 3 | 26 | 96 | 164 | 171 | |
| EPS in Rs | -3.38 | 0.13 | 1.37 | 4.95 | 8.50 | 8.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 86% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 305% |
| TTM: | 49% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 1% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 2% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 5 | 193 | 193 | 193 | 193 |
| Reserves | -5 | 3,883 | 3,904 | 4,032 | 4,215 |
| 2 | 256 | 140 | 39 | 26 | |
| 5 | 1,794 | 1,792 | 1,864 | 1,902 | |
| Total Liabilities | 7 | 6,127 | 6,029 | 6,128 | 6,337 |
| 0 | 5,505 | 5,481 | 5,463 | 5,471 | |
| CWIP | 0 | 0 | 2 | 1 | 2 |
| Investments | 0 | 62 | 76 | 55 | 59 |
| 7 | 560 | 470 | 609 | 804 | |
| Total Assets | 7 | 6,127 | 6,029 | 6,128 | 6,337 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0 | 37 | 181 | 194 | 246 | |
| 0 | 12 | -26 | -32 | -168 | |
| -0 | -31 | -154 | -120 | -43 | |
| Net Cash Flow | -0 | 18 | 1 | 43 | 34 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 110 | 144 | 22 | 23 | 27 |
| Inventory Days | 109 | 656 | 96 | 104 | 92 |
| Days Payable | 256 | 499 | 91 | 80 | 66 |
| Cash Conversion Cycle | -37 | 300 | 27 | 47 | 52 |
| Working Capital Days | -105 | -522 | -97 | -83 | -70 |
| ROCE % | 1% | 2% | 4% | 5% |
Documents
Announcements
-
Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2025
31 Oct - Board meeting Nov 13, 2025 to approve unaudited standalone and consolidated Q2/H1 results ended Sep 30, 2025.
-
Announcement Under Regulation 30
16 Oct - Order (Oct 9, 2025) demands Rs16,22,32,387 (incl. Rs8,08,79,410 penalty) for FY2018–19 to 2022–23; company to appeal.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Oct - Registrar MUFG Intime certifies dematerialisation confirmations for quarter ended September 30, 2025.
- Closure of Trading Window 25 Sep
-
Intimation Of Schedule Of Analyst/Institutional Investor Meeting Under Regulation 30 Of SEBI LODR
19 Sep - Non-deal roadshow on Sep 24-25, 2025 in Singapore by Nuvama Institutional Equities.
Annual reports
Concalls
-
Aug 2025Transcript PPT
-
May 2025TranscriptPPTREC
-
May 2025TranscriptNotesPPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT REC
-
Feb 2023TranscriptNotesPPT
Flagship Products[1]
Aquaguard is the award-winning water purifier brand of Eureka Forbes. The Forbes vacuum cleaners are market leaders of the company and remain as #1 vacuum cleaner brand in 2020-21. Other products under the Eureka Forbes umbrella include Dr. Aeroguard, Forbes Health Conditioner, and Air purifiers.